Abstract
Celiac disease is an autoimmune disorder with genetic and environmental components. The prevalence of the disease is about 1 % in many parts of the world. It is characterized by innate and adaptive immune responses that are primarily triggered by the ingestion of dietary gluten, resulting in inflammation, villous atrophy, and crypt hyperplasia in the small intestine. Genes that code for human leukocyte antigens (HLA) DQ2 and DQ8 are strongly associated with and confer susceptibility for celiac disease. In addition to the characteristic intestinal symptoms, celiac disease is associated with extra-intestinal complications, including those affecting skeletal health. Reduction in bone mineral density and increased risk of bone fracture, caused by malabsorption-related alteration of calcium metabolism and immune-mediated mechanisms, are frequently seen in patients with celiac disease. The diagnosis of celiac disease relies on serologic testing and intestinal biopsy. Bone density evaluation is recommended within 1 year of diagnosis and treatment. Gluten-free diet is the recommended treatment for celiac disease, usually resulting in the gradual recovery of intestinal mucosa, which leads to elimination of calcium and vitamin deficiencies and progression towards normalization of bone density. This chapter summarizes the currently available information regarding the prevalence, pathogenic mechanism, and treatment of celiac disease in the context of bone health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:613–21.
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005;142:289–98.
Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev. 2008;7:644–50.
Joplin GF, Melvin KE, Hepner GW, Neale G, Bordier P. Calcium metabolism and bone histology in adult celiac disease. Calcif Tissue Res. 1968;2(1 Suppl):62.
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–44. quiz 1537, 1545.
Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.
Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–8.
Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–95.
Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens. 2003;61:105–17.
van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007;39:827–9.
Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008;40:395–402.
Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193–201.
Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–43.
Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126–31.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–92.
Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun. 1999;13:143–8.
Lampasona V, Bonfanti R, Bazzigaluppi E, Venerando A, Chiumello G, et al. Antibodies to tissue transglutaminase C in type I diabetes. Diabetologia. 1999;42:1195–8.
Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23:464–83.
Mainardi E, Montanelli A, Dotti M, Nano R, Moscato G. Thyroid-related autoantibodies and celiac disease: a role for a gluten-free diet? J Clin Gastroenterol. 2002;35:245–8.
O’Leary C, Walsh CH, Wieneke P, O’Regan P, Buckley B, et al. Coeliac disease and autoimmune Addison’s disease: a clinical pitfall. QJM. 2002;95:79–82.
Rostami K, Steegers EA, Wong WY, Braat DD, Steegers-Theunissen RP. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol. 2001;96:146–9.
Meloni GF, Dessole S, Vargiu N, Tomasi PA, Musumeci S. The prevalence of coeliac disease in infertility. Hum Reprod. 1999;14:2759–61.
Corazza GR, Andreani ML, Venturo N, Bernardi M, Tosti A, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology. 1995;109:1333–7.
Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry. 1999;67:257.
Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 2001;49:540–3.
Shill HA, Alaedini A, Latov N, Hallett M. Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration. Neurology. 2003;60:1672–3.
Alaedini A, Green PH, Sander HW, Hays AP, Gamboa ET, et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol. 2002;127:145–8.
Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry. 2003;74:490–4.
Chin RL, Sander HW, Brannagan TH, Green PHR, Hays AP, et al. Celiac neuropathy. Neurology. 2003;60:1581–5.
Luostarinen L, Dastidar P, Collin P, Peraaho M, Maki M, et al. Association between coeliac disease, epilepsy and brain atrophy. Eur Neurol. 2001;46:187–91.
Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, et al. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003;98:625–9.
Curione M, Barbato M, De Biase L, Viola F, Lo Russo L, et al. Prevalence of coeliac disease in idiopathic dilated cardiomyopathy. Lancet. 1999;354:222–3.
Frustaci A, Cuoco L, Chimenti C, Pieroni M, Fioravanti G, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.
Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol. 2000;14:672–5.
Sjoberg K, Lindgren S, Eriksson S. Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease. Scand J Gastroenterol. 1997;32:1162–7.
Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.
Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002;87:293–6.
Ransford RA, Hayes M, Palmer M, Hall MJ. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol. 2002;35:228–33.
Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma VM, et al. Osteoporosis in adult patients with celiac disease. Bone. 1999;24:249–55.
Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and “Club del Tenue” Working Groups on Coeliac Disease. Gut. 1998;42:362–5.
Iltanen S, Collin P, Korpela M, Holm K, Partanen J, et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren’s syndrome. Am J Gastroenterol. 1999;94:1042–6.
Lepore L, Martelossi S, Pennesi M, Falcini F, Ermini ML, et al. Prevalence of celiac disease in patients with juvenile chronic arthritis. J Pediatr. 1996;129:311–3.
Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495–8.
Agardh D, Nilsson A, Carlsson A, Kockum I, Lernmark A, et al. Tissue transglutaminase autoantibodies and human leucocyte antigen in Down’s syndrome patients with coeliac disease. Acta Paediatr. 2002;91:34–8.
Ventura A, Martelossi S. Dental enamel defects and coeliac disease. Arch Dis Child. 1997;77:91.
Aine L, Maki M, Collin P, Keyrilainen O. Dental enamel defects in celiac disease. J Oral Pathol Med. 1990;19:241–5.
Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395–8.
Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol. 2003;1:19–27.
Dupont FM, Vensel WH, Tanaka CK, Hurkman WJ, Altenbach SB. Deciphering the complexities of the wheat flour proteome using quantitative two-dimensional electrophoresis, three proteases and tandem mass spectrometry. Proteome Sci. 2011;9:10.
Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev. 2005;206:219–31.
Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333–40.
Qiao SW, Iversen R, Raki M, Sollid LM. The adaptive immune response in celiac disease. Semin Immunopathol. 2012;34:523–40.
Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity. 2008;41:19–26.
Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:639–60.
Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209:2395–408.
Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795–841.
Fouda MA, Khan AA, Sultan MS, Rios LP, McAssey K, et al. Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol. 2012;26:819–29.
Vasquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol. 2000;95:183–9.
Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM. Coeliac disease and the risk of fractures - a general population-based cohort study. Aliment Pharmacol Ther. 2007;25:273–85.
Olmos M, Antelo M, Vazquez H, Smecuol E, Maurino E, et al. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis. 2008;40:46–53.
Barera G, Mora S, Brambilla P, Ricotti A, Menni L, et al. Body composition in children with celiac disease and the effects of a gluten-free diet: a prospective case-control study. Am J Clin Nutr. 2000;72:71–5.
Sonti R, Lebwohl B, Lewis SK, Abu Daya H, Klavan H, et al. Men with celiac disease are shorter than their peers in the general population. Eur J Gastroenterol Hepatol. 2013;25(9):1033–7.
Street ME, Volta C, Ziveri MA, Zanacca C, Banchini G, et al. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol (Oxf). 2008;68:22–8.
Federico G, Favilli T, Cinquanta L, Ughi C, Saggese G. Effect of celiac disease and gluten-free diet on growth hormone-binding protein, insulin-like growth factor-I, and insulin-like growth factor-binding proteins. Horm Res. 1997;48:108–14.
Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull. 2008;86:77–93.
Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys. 2010;503:54–65.
Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012;41:557–69.
Tavakkoli A, DiGiacomo D, Green PH, Lebwohl B. Vitamin D status and concomitant autoimmunity in celiac disease. J Clin Gastroenterol. 2013;47:515–9.
Fraser WD. Hyperparathyroidism. Lancet. 2009;374:145–58.
Pearson DA. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract. 2007;22:517–44.
Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228:1149–53.
Mager DR, Qiao J, Turner J. Vitamin D and K status influences bone mineral density and bone accrual in children and adolescents with celiac disease. Eur J Clin Nutr. 2012;66:488–95.
Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr. 1999;69:354–65.
Fornari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, et al. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol. 1998;93:413–8.
Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res. 2004;19:1112–21.
Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15:2–12.
Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.
Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888–94.
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.
Rashtak S, Ettore MW, Homburger HA, Murray JA. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2008;6:426–32.
Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–4.
Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.
Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S. Diagnosis of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:661–77.
Simpson S, Thompson T. Nutrition assessment in celiac disease. Gastrointest Endosc Clin N Am. 2012;22:797–809.
Lee SK, Lo W, Memeo L, Rotterdam H, Green PH. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc. 2003;57:187–91.
Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008;6:314–20.
Corazza GR, Di Stefano M, Jorizzo RA, Cecchetti L, Minguzzi L, et al. Propeptide of type I procollagen is predictive of posttreatment bone mass gain in adult celiac disease. Gastroenterology. 1997;113:67–71.
Troncone R, Kosova R. Short stature and catch-up growth in celiac disease. J Pediatr Gastroenterol Nutr. 2010;51 Suppl 3:S137–8.
Lebwohl B, Michaelsson K, Green PH, Ludvigsson JF. Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab. 2014;99:609–16.
Pazianas M, Butcher GP, Subhani JM, Finch PJ, Ang L, et al. Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake. Osteoporos Int. 2005;16:56–63.
Thompson T. Gluten contamination of commercial oat products in the United States. N Engl J Med. 2004;351:2021–2.
Questions and answers: gluten-free food labeling final rule. U.S. Food and Drug Administration. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/Allergens/ucm362880.htm. 2014; Accessed 10/12/2014.
Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med. 2011;269:604–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Alaedini, A. (2015). Celiac Disease and Bone Health. In: Holick, M., Nieves, J. (eds) Nutrition and Bone Health. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2001-3_37
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2001-3_37
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2000-6
Online ISBN: 978-1-4939-2001-3
eBook Packages: MedicineMedicine (R0)